Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

2015 ◽  
Vol 17 (5) ◽  
pp. 511-515 ◽  
Author(s):  
S.-M. Jin ◽  
S. W. Park ◽  
K.-H. Yoon ◽  
K. W. Min ◽  
K.-H. Song ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Phase Iii ◽  
Double Blind ◽  
Phase Iii Clinical Trial

Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

2021 ◽  
pp. 1-10
Author(s):  
Joana Furtado de Figueiredo Neta ◽  
Vivian Saraiva Veras ◽  
Danilo Ferreira de Sousa ◽  
Maria da Conceição dos Santos Oliveira Cunha ◽  
Maria Veraci Oliveira Queiroz ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Metabolic Control ◽  
Curcuma Longa ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial

2012 ◽  
Vol 20 (1) ◽  
Author(s):  
Ramin Heshmat ◽  
Ozra Tabatabaei-Malazy ◽  
Shabnam Abbaszadeh-Ahranjani ◽  
Samimeh Shahbazi ◽  
Ghazal Khooshehchin ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Vitamin D ◽  
Anthropometric Parameters ◽  
Double Blind ◽  
Double Blind Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document